Industries
Healthy-Aging & Longevity Economy
What changes this industry: bio-solutions with evidence, technologies, suppliers and open money.
Overview of the industry
Biotechnology aimed at the biology of ageing: senolytics and geroscience, partial epigenetic reprogramming, epigenetic clocks and biological-age diagnostics, and cell-based approaches. Therapeutics and the companies developing them are in scope; consumer wellness products are listed under Wellness & preventive bio-living and Consumer & retail.
What it replaces 0
No graded substitution linked yet.
Technologies 4
| Epigenetic clocks & biological-age diagnostics Reading DNA-methylation patterns across hundreds of thousands of CpG sites to compute a person's biological age and pace of aging, rather than the calendar age … | Diagnostics & medtech |
| Geroscience & senolytics Selectively clearing senescent 'zombie' cells or suppressing their inflammatory secretome to treat age-related disease at its molecular root, rather than one … | Regenerative & personalized medicine |
| Induced pluripotent stem cells (iPSC) Reprogramming adult cells into an embryonic-like, expandable stem state — the platform behind off-the-shelf NK cells, defined culture media and human-iPSC … | Regenerative & personalized medicine |
| Partial epigenetic reprogramming Transient expression of Yamanaka reprogramming factors to reverse epigenetic markers of cellular aging without erasing cell identity — OSK gene therapy, … | Regenerative & personalized medicine |
Opportunities 3
| Grant | Crafting routes to a circular economy European Commission | Sep 23, 2027 342 days |
| Grant | International dimension of the circular bio-based economy: seeking win-win opportunities European Commission | May 11, 2027 207 days |
| Grant | Resilient economy and security through ecosystem transitions grants UKRI | Oct 22, 2026 6 days |